|
⚲
|
| Keyboard |
| QVT Financial LP
✚
|
|
|---|---|
| CRD # | 156508 |
| SEC # | 801-73049 |
| CIK # | 0001290162 |
| AUM | 1,786.7 M (2026-03-31) |
| Employees | 31 (26% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-705-8888 |
| Address | 888 Seventh Avenue New York, NY 10106 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
FEES AND COMPENSATION
A. Advisory Services and Fees.
Management Fees
With respect to the Family Office Funds, investors are charged a monthly management
fee, in arrears, based on the net asset value of the assets under management, typically at a
rate of 1.75% per annum.
With respect to the Fourth Avenue Funds, investors are not charged any management fee,
unless specifically agreed.
Incentive Allocation/Incentive Fees/Carried Interest
Further, Clients structured as hedge funds also may be charged an annual incentive
allocation/fee depending upon the investment mandate. Investors in the Private Funds
(“Fund Investors”) that are withdrawing or redeeming other than at a fiscal year end will
bear any incentive allocation/fee accrued at a date earlier than the year-end (i.e., through
such withdrawal or redemption date).
The incentive allocation for the Family Office Funds is (i) 17.5% for the master fund or
intermediate fund, as the case may be; and (ii) 15% for side pockets, determined only on
the basis of realized or partially realized side pocket investments.
The respective offering documents and/or organizational documents will generally permit
the Adviser or the Private Fund the ability to waive, rebate or reduce all or part of the
management fee and/or performance compensation with respect to investments made by
certain investors without waiving, rebating or reducing the management fee and/or
performance compensation charged/payable to other investors (such as the case of, but
not limited to, investments made by the Adviser, its Affiliates, its partners/employees and
their family members in a Private Fund).
B. Payment of Fees.
Fees and compensation paid to the Adviser or its Affiliates by the Private Funds are
generally deducted from the assets of such Private Funds. As discussed above,
management fees are generally deducted on a monthly or quarterly basis and performance
compensation is generally deducted on an annual basis.
C. Additional Expenses and Fees.
A Private Fund may bear operating and other expenses including, but not limited to, the
following:
• investment expenses, including without limitation, expenses that are related to the
investment of the Private Fund’s assets, such as:
o brokerage commissions and other costs of executing transactions,
o investment-related travel expenses (which are travel expenses incurred by the
Advisers related to the purchase, sale, transmittal or ongoing monitoring of
the Private Fund’s investments),
o interest expenses,
o finance charges and clearing fees,
o applicable withholding and other taxes,
o consulting and other professional fees related to particular investments, and
o legal, accounting, due diligence and other similar expenses attributable to
investments (even if such investments are not consummated).
• fees and expenses relating to software tools, programs or other technology utilized in
managing the Private Funds, including, without limitation, technology to measure
risk,
• research and market data (including, without limitation, any computer hardware and
telephone and data lines incorporated into the cost of obtaining such research and
market data),
• administrative expenses, including, without limitation,
o the monthly service fees and expenses of an administrator,
o paying agency, transfer agency, local representative, accounting verification
(if any) and/or investor registrar services,
o costs and expenses relating to the Private Fund’s regulatory compliance,
including, without limitation, the costs of regulatory inquiries and regulatory
filings, registrations and memberships,
• legal expenses, such as
o legal fees charged in negotiating prime brokerage, ISDA master agreements
and related custody and segregation agreements, repurchase agreements or
other trading or financing agreements,
o the costs of revising the Private Fund’s offering and operative documents,
• internal and external accounting and valuation expenses,
• audit and tax preparation and filing expenses, such as
o tax advisory fees,
o the costs of FATCA, OECD Common Reporting Standard and other tax-
related compliance,
• insurance premiums (including, without limitation, Director and Officer liability
and/or Errors & Omissions insurance, including for indemnified parties),
• custodial fees,
• entity-level taxes,
• organizational expenses,
• offering expenses (including, without limitation, costs associated with compliance
with AIFMD and other local offering requirements),
• other expenses associated with the operation of such Private Fund, and
• extraordinary expenses.
D. Prepayment of Fees.
Please see responses to 5A above.
E. Compensation for Sale of Securities or Other Investment Products.
Neither the Adviser, its Affiliates, nor any of their supervised persons accept
compensation for the sale of securities or other investment products. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
TYPES OF CLIENTS The clients to whom the Adviser and its Affiliates provide investment management services and advice are the Private Funds. The offering documents of each Private Fund may set minimum amounts for investment by prospective investors in such Private Funds. These minimum amounts may be waived by the Adviser or an Affiliate, except to the extent prohibited by law. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Roivant Sciences Ltd | 0.7 | ||
| Okeanis ECO Tankers Corp | 0.1 | ||
| Carvana Co | 0.1 | ||
| Goldman Sachs Group Inc | 0.0 | ||
| Allot Communications Ltd | 0.0 | ||
| Nelnet Inc | 0.0 | ||
| Nexstar Broadcasting Group Inc | 0.0 | ||
| New York Times Co | 0.0 | ||
| Nvidia Corp | 0.0 | ||
| Apple Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | Fourth Avenue FF Opportunities LP - Series 11 | 2026-03-31 | 21.8 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 12 | 2026-03-31 | 2.5 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 13 | 2026-03-31 | 3.5 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 14 | 2026-03-31 | 1.0 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 15 | 2026-03-31 | 6.1 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 16 | 2026-03-31 | 3.0 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 17 | 2026-03-31 | 0.1 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 18 | 2026-03-31 | 5.7 M | |
| Other | QVT Gilead Holdings LLC | 2026-03-31 | 13.0 M | |
| Other | Fourth Avenue FF Opportunities LP - Series 10 | 2025-03-31 | 0.4 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 1.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 1.8 |
| By Discretionary | ||
| Discretionary | 7 | 1.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 1.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.8 | |
| United States Persons | 1.0 | |
| Total | 7 | 1.8 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Ian Pilgrim | Director | 148 | 19 | |
| William Woods | Director | 23 | 6 | |
| W Woods | Director | 68 | 5 | |
| Daniel Gold | Executive Officer | 27 | 2 | |
| Arthur Chu | Executive Officer | 20 | 2 | |
| Nicholas Brumm | Executive Officer | 19 | 2 | |
| Tracy Fu | Executive Officer | 17 | 2 | |
| Qvt Associates GP LLC | Executive Officer | 8 | 2 | |
| Qvt Associates GP | Executive Officer | 5 | 2 | |
| Qvt Financial LP | Executive Officer | 4 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001290162] | |
| 3 | [0001290162] | |
| 4 | [0001290162] | |
| SC 13D | [0001290162] | |
| SC 13G | [0001290162] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $8.9B |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 549300JMMSS9C5S2HO30 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Roivant Sciences Ltd | |
| QVT Financial LP | |
| Okeanis Eco Tankers Corp | |
| MP Materials Corp / DE | |
| QVT Financial GP LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-13 | Sell | 150,784 | $26.49 | 3,994,268 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-13 | Sell | 225,000 | $26.50 | 5,962,500 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-12 | Sell | 150,000 | $26.72 | 4,008,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-12 | Sell | 275,000 | $26.76 | 7,359,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2026-02-11 | Sell | 425,000 | $26.67 | 11,334,750 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-17 | Sell | 432,718 | $23.05 | 9,974,150 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-17 | Sell | 155,076 | $23.02 | 3,569,850 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-17 | Sell | 189,538 | $23.17 | 4,391,595 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-16 | Sell | 275,000 | $22.93 | 6,305,750 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-12-16 | Sell | 642,282 | $23.08 | 14,823,869 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-11-19 | Sell | 175,000 | $20.24 | 3,542,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-11-19 | Sell | 150,000 | $20.20 | 3,030,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-11-19 | Sell | 125,000 | $20.16 | 2,520,000 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-11-19 | Sell | 850,000 | $20.25 | 17,212,500 |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 6,837,266 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 6,205,368 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 3,176,245 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 19,311,790 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 55,443 | $0.00 | |
|
Roivant Sciences Ltd ROIV
Common Shares
|
2025-06-25 | Other | 1,170,646 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
D2 Asset Management LP
✚
|
TX | 1,825.9 M |
|
ParaFi Capital LP
✚
|
NY | 1,817.8 M |
|
Tensile Capital Management LP
✚
|
CA | 1,796.0 M |
|
Morgan Creek Capital Management LLC
✚
|
NC | 1,790.2 M |
|
Alta Park Capital LP
✚
|
CA | 1,779.6 M |
|
Great Point Partners LLC
✚
|
CT | 1,777.1 M |
|
OFS Capital Management LLC
✚
|
IL | 1,760.0 M |
|
RCF Management LLC
✚
|
CO | 1,757.0 M |
|
Parkman Healthcare Partners LLC
✚
|
CT | 1,744.0 M |
|
Long Path Partners LP
✚
|
CT | 1,732.8 M |